Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease

Background: How to handle patients with anti-tumor necrosis factor (anti-TNF) failure was a common challenge to clinicians in Crohn’s disease (CD). The present study is dedicated to clarifying whether fecal microbiota transplantation (FMT) could be a switch therapy for patients with prior failure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qianqian, Ding, Xiao, Liu, Yujie, Marcella, Cicilia, Dai, Min, Zhang, Ting, Bai, Jianling, Xiang, Liyuan, Wen, Quan, Cui, Bota, Zhang, Faming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166050/
https://www.ncbi.nlm.nih.gov/pubmed/34079458
http://dx.doi.org/10.3389/fphar.2021.658087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166050/
https://www.ncbi.nlm.nih.gov/pubmed/34079458
http://dx.doi.org/10.3389/fphar.2021.658087

Ejemplares similares